EGFR antibody (C-Term)
Quick Overview for EGFR antibody (C-Term) (ABIN870533)
Target
See all EGFR AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 1120-1135, C-Term
-
Purpose
- Anti-EGFR
-
Specificity
- EGFR
-
Immunogen
- Peptide derived from C-terminal region of human epidermal growth factor receptor (EGFR). Antibody recognizes the epitope between Ser1120 - Asn1135.
-
Isotype
- IgG
-
-
-
-
Application Notes
- 1:100 - 200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 20 mM Tris-HCI, pH 8.0, Stabilizer: 20 mg/mL BSA, Preservative: 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- +2 °C to +8 °C
-
-
- EGFR (Epidermal Growth Factor Receptor (EGFR))
-
Alternative Name
- EGFR
-
Background
- Epidermal Growth Factor Receptor (EGFR) is the prototype member of the type 1 receptor tyrosine kinases. EGFR overexpression in tumors indicates poor prognosis and is observed in tumors of the head and neck, brain, bladder, stomach, breast, lung, endometrium, cervix, vulva, ovary, esophagus, colon and in squamous cell carcinoma.
-
UniProt
- P00533
-
Pathways
- NF-kappaB Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Stem Cell Maintenance, Hepatitis C, Positive Regulation of Response to DNA Damage Stimulus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation, S100 Proteins
Target
-